BioCentury
ARTICLE | Company News

Regeneron deal

October 10, 1994 7:00 AM UTC

Regeneron Pharmaceuticals Inc. (REGN) REGN received a $1.6 million manufacturing payment from Sumitomo Pharmaceuticals Co. Ltd., under the companies' collaboration to develop brain-derived neurotrop...